IN-IAC
2.5.2024 20:01:27 CEST | Business Wire | Press release
The Indy Autonomous Challenge (IAC) will make a grand return to the Indianapolis Motor Speedway (IMS) “The Racing Capital of the World” on September 6th, 2024. The competition is set to be a landmark event, featuring a head-to-head race of the world’s fastest autonomous racecars piloted by AI driver software developed by 10 teams representing 18 top universities from North America, Europe, and Asia.
History was made at IMS in October 2021 when IAC organized the world’s first head-to-head high-speed autonomous racing competition. Since then, IAC has organized five races at iconic tracks, including Las Vegas Motor Speedway during CES and the Monza F1 Circuit in Italy. IAC and its university teams have achieved a long list of world records for high-speed ground-based autonomy. World records include the autonomous land speed record (192.2 mph), the top speed on-track (180 mph), the fastest on-track head-to-head overtake (177 mph), and most miles of autonomous racing (7,500 miles).
“Three years ago, we gathered the best and brightest minds from universities around the world to make history at Indianapolis Motor Speedway, proving that autonomous racing is possible and launching a global effort to accelerate the pursuit of high-speed autonomous mobility,” said Paul Mitchell, President of the Indy Autonomous Challenge. “After setting many records and proving that autonomous vehicles can race at extreme speeds, we are returning home to the Racing Capital of the World to attempt an even more ambitious head-to-head race.”
The upcoming race at IMS, which is being held in partnership with the Indiana Economic Development Corporation (IEDC), will be a high-adrenaline head-to-head race of multiple IAC AV-24 autonomous racecars. Teams from leading research universities worldwide will push the limits of autonomous technology, competing at breathtaking speeds on the iconic oval track. This race promises not just to entertain but to offer a glimpse into the future of mobility, where AI drivers can operate autonomous vehicles safely on highways at high speeds, reducing the risk of accidents and speeding up supply chain logistics.
“Indiana is a leader in the future of mobility, attracting new business investment, fostering R&D and inspiring innovation across EV, hydrogen and autonomy,” said Indiana Secretary of Commerce David Rosenberg. “The technologies, companies and talent being assembled by the Indy Autonomous Challenge are making significant strides in developing autonomous capabilities, putting Indiana at the forefront of tomorrow’s global economy while inspiring the next generation of leaders and risktakers.”
With 10 teams representing 18 universities from five countries, the race will be the world’s largest autonomous racing competition.
- AI Racing Tech - University of California, Berkeley (California), with University of Hawai'i (Hawai’i), University of California, San Diego (California), and Carnegie Mellon University
- Autonomous Tiger Racing - Auburn University (Alabama)
- Black & Gold Autonomous Racing - Purdue University (Indiana)
- Cavalier Autonomous Racing - University of Virginia (Virginia)
- KAIST - Korea Advanced Institute of Science and Technology (South Korea)
- Luddy Autonomous Racing – Indiana University (Indiana)
- MIT-PITT-RW - Massachusetts Institute of Technology (Massachusetts), University of Pittsburgh (Pennsylvania), Rochester Institute of Technology (New York), and University of Waterloo (Canada)
- PoliMOVE-MSU - Politecnico di Milano (Italy), Michigan State University (Michigan), University of Alabama (Alabama)
- TUM Autonomous Motorsport - Technische Universität München (Germany)
- UNIMORE Racing - University of Modena and Reggio Emilia (Italy)
“The Indianapolis Motor Speedway was originally built as a test bed for early automobiles,” said J. Douglas Boles, President of IMS. “Having teams from the world’s most elite research universities using the track to prove out the future of autonomous vehicles connects the track’s historic roots to the future of AI and robotics.”
The race will attract thousands of attendees from government, industry, and academia including 2,000 high school students studying Science, Technology, Engineering, and Math (STEM). The race event will be live-streamed worldwide for those who cannot attend in person.
“For many Hoosiers, your first trip to the Indianapolis Motor Speedway is a rite of passage,” said Indiana Secretary of Education Katie Jenner. “The Indy Autonomous Challenge provides a unique opportunity for students to visit the track and experience first-hand the incredible STEM technologies being developed right here in Indiana. We are excited to help recruit high school students to attend the event and partner in the planning of a STEM Zone that will connect them directly to future college and career opportunities.”
In addition to the “main event” head-to-head race, the day will include several interactive events and activations that will offer attendees a chance to learn about and engage with technologies of the future including autonomous vehicles, drones, robots, augmented and virtual reality, generative AI, sensor fusion, internet of things, etc. Activations will include:
- Innovation Paddock: Interactive hard-tech exhibits by industry-leading companies, start-ups, universities, and innovation-based non-profits will be located in the Trackside Garages adjacent to the track. Here, attendees can interact with the latest technology advancements in mobility, AI, automation, robotics, and more.
- Future Mobility Summit: An invitation-only summit centered around breakthrough advancements such as AI-driven autonomy, next-generation drones, smart infrastructure, and sustainable energy solutions, with a special focus on Indiana’s innovative contributions, the summit promises an unparalleled convergence of thought leaders from industry, government, and academia. This curated event, designed to spark meaningful discussions and foster policy development to accelerate the advent of future mobility, will feature dynamic keynotes and panel sessions steered by renowned figures from leading industry circles.
- STEM Zone: Created in partnership with the Indiana Department of Education and dedicated to inspiring the next generation of innovators, the STEM Zone will engage students with interactive exhibits and educational sessions focused on science, technology, engineering, and mathematics underscoring the IAC's commitment to fostering curiosity and passion for STEM among youth, highlighting the critical role of education in the future of technology. Students will also have access to Innovation Paddock exhibitions, sponsored lunch concessions, and seating in the Tower Terrace Grandstands to watch the IAC race.
Companies, governments, universities, and non-profits interested in participating in the Indy Autonomous Challenge at IMS can contact info@indyautonomouschallenge.com. High School administrators or teachers interested in bringing students to the event can contact EEL@doe.in.gov. General attendees who would like to attend the race event can purchase tickets on the Indianapolis Motor Speedway website starting May 2nd, 2024.
About the IAC: The Indy Autonomous Challenge (IAC) is a non-profit corporation based in Indianapolis, Indiana (USA) which organizes racing competitions among university-affiliated teams representing 18 universities from around the world. Teams program AI drivers to pilot fully autonomous IAC racecars and compete in a series of history-making events at iconic tracks. Based in Indiana, the IAC is working to establish a hub for performance automation in the state and is harnessing the power of innovative competitions to attract the best and the brightest minds from around the globe to further state-of-the-art technology in safety and performance of automated vehicles. The IAC started as a $1 million prize competition with 31 university teams signing up to compete more than three years ago, representing top engineering and technology programs from 15 U.S. states and 11 countries. Follow the IAC @IndyAChallenge on LinkedIn, Twitter, Instagram, Facebook, & YouTube.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240502559440/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
